Geminin overexpression promotes imatinib sensitive breast cancer: a novel treatment approach for aggressive breast cancers, including a subset of triple negative.

Geminin overexpression promotes imatinib sensitive breast cancer: a novel treatment approach for aggressive breast cancers, including a subset of triple negative.

Breast cancer is the second leading cause of cancer-related deaths in women. Triple negative breast cancer (TNBC) is an aggressive subtype that affects 10-25% mostly African American women. TNBC has the poorest prognosis of all subtypes with rapid progression leading to mortality in younger patients...

Full description

Bibliographic Details
Main Authors: Zannel Blanchard, Nicole Mullins, Pavani Ellipeddi, Janice M Lage, Shawn McKinney, Rana El-Etriby, Xu Zhang, Raphael Isokpehi, Brenda Hernandez, Wael M Elshamy
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4005756?pdf=render

Similar Items

Similar Items